Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AUTL | REPL | ERAS | ||
| Company | Autolus Therapeutics Plc ADR | Replimune Group Inc | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.83 | 11.14 | 2.66 | ||
| High | 2.89 | 11.35 | 2.67 | ||
| Low | 2.69 | 11.00 | 2.51 | ||
| Last | 2.84 | 11.05 | 2.60 | ||
| Change | +0.04 | -0.18 | -0.04 | ||
| % Change | +1.43% | -1.60% | -1.52% | ||
| Volume | 3,816,100 | 882,200 | 1,640,100 | ||
| 20-Day Average Volume | 2,680,305 | 524,055 | 1,736,130 | ||
| Previous Close | 2.80 | 11.23 | 2.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.50 | 11.79 | 2.83 | ||
| 20-Day Raw Stochastic | 7.50% | 20.00% | 18.50% | ||
| 20-Day Relative Strength | 35.85% | 46.04% | 44.64% | ||
| Weighted Alpha | -50.96 | +8.10 | -3.82 | ||
| Today's Opinion | 100% Sell | 56% Buy | 32% Buy | ||
| Previous Opinion | 100% Sell | 56% Buy | 32% Buy | ||
| Last Month's Opinion | 8% Buy | 100% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.65% since 11/14/24 | -3.07% since 11/14/24 | -7.47% since 11/14/24 | ||
| Low | 2.69 on 11/21/24 | 10.57 on 11/19/24 | 2.51 on 11/21/24 | ||
| High | 3.25 on 11/18/24 | 11.50 on 11/15/24 | 2.97 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -37.17% since 10/21/24 | -2.64% since 10/21/24 | -4.76% since 10/21/24 | ||
| Low | 2.69 on 11/21/24 | 10.57 on 11/19/24 | 2.44 on 10/28/24 | ||
| High | 4.69 on 10/28/24 | 12.97 on 11/11/24 | 3.31 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | -30.39% since 08/21/24 | +7.59% since 08/21/24 | -8.45% since 08/21/24 | ||
| Low | 2.69 on 11/21/24 | 9.84 on 08/28/24 | 2.41 on 10/08/24 | ||
| High | 5.00 on 10/18/24 | 12.97 on 11/11/24 | 3.31 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | -26.61% since 05/21/24 | +98.38% since 05/21/24 | +10.64% since 05/21/24 | ||
| Low | 2.69 on 11/21/24 | 4.92 on 05/29/24 | 1.96 on 06/18/24 | ||
| High | 5.00 on 10/18/24 | 12.97 on 11/11/24 | 3.45 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 755,707 | 756,008 | 735,090 | ||
| Shares Outstanding, K | 266,094 | 68,417 | 282,727 | ||
| Annual Sales | 1,700,000 | 0 | 0 | ||
| Annual Net Income | -208,380,000 | -215,790,000 | -125,040,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -58,270,000 | -53,060,000 | -31,200,000 | ||
| 60-Month Beta | 2.04 | 1.19 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/12/24 | -0.68 on 11/12/24 | -0.11 on 11/12/24 | ||
| Latest Earnings Date | 11/12/24 | 11/12/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||